Clinical Trial Update: Pembrolizumab Plus Lenvatinib in Previously Treated Classic Kaposi Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial of pembrolizumab plus lenvatinib for previously treated classic Kaposi sarcoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Classic Kaposi Sarcoma
• Kaposi Sarcoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• LENVIMA (lenvatinib)

Snippet

Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Conditions: Kaposi Sarcoma, Classic Kaposi Sarcoma | Phase 2 | Status: WITHDRAWN